TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
3.8000
+3.6000 (1800.00%)
TC BioPharm (Holdings) plc is a biotechnology company focused on developing innovative cell therapies for the treatment of cancer and other serious diseases
The company specializes in harnessing the power of the immune system, specifically employing techniques involving gamma delta T-cells, to create advanced therapeutics aimed at enhancing patient outcomes. Through rigorous research and clinical trials, TC BioPharm is dedicated to bringing transformative treatments to patients suffering from a variety of conditions, ultimately striving to improve healthcare and expand therapeutic options in the field of oncology and beyond.
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · February 10, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · February 10, 2025
![](https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp)
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 10, 2025
![](https://cdn.benzinga.com/files/images/story/2024/08/14/1.png?width=1200&height=800&fit=crop)
TC BioPharm shares are trading lower by 44% Wednesday morning. The company announced the pricing of an offering of 2 million units at $1 per unit.
Via Benzinga · August 14, 2024
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
TC BioPharm stock is down on Wednesday after the company priced shares of TCBP in a registered direct offering.
Via InvestorPlace · August 14, 2024
![](https://cdn.benzinga.com/files/images/story/2025/02/10/TCBP.png?width=1200&height=800&fit=crop)
TC BioPharm's Phase 2B trial of TCB008 in AML progresses as the first Cohort B patient completes dosing. Enrollment continues, with data expected in 2025.
Via Benzinga · February 10, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 18, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/18/TCBP.png?width=1200&height=800&fit=crop)
TC BioPharm to issue a special dividend of 0.25 ADS per share, pending shareholder approval at the December 30 meeting. Record date: January 2, 2025.
Via Benzinga · December 18, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 29, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 15, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/28/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 28, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 22, 2024
![](https://cdn.benzinga.com/files/images/story/2024/10/22/Apple--Nio--CVS-Health--Stellantis--Tesl.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 22, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 21, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 7, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 27, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 26, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/03/movers-image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 3, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/29/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 29, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!
Via InvestorPlace · August 14, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/14/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 14, 2024
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via InvestorPlace · July 9, 2024